Squamous cell carcinoma of the skin: Epidemiology, classification, management, and novel trends

International Journal of Dermatology

Volumn 54, Issue 2, 2015, Pages 130-140

  Kallini, Joseph R ^a,b   Hamed, Nouran ^c   Khachemoune, Amor ^d,e  

^a EISENHOWER MEDICAL CENTER   (United States)

^b Baylor College of Medicine   (United States)

^c ALEXANDRIA UNIVERSITY   (Egypt)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMINOLEVULINIC ACID METHYL ESTER; BLEOMYCIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; IMIQUIMOD; LIQUID NITROGEN;

ACTINIC KERATOSIS; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CHEILITIS; CLINICAL FEATURE; CRYOSURGERY; CRYOTHERAPY; CURETTAGE; DESICCATION; DIFFERENTIAL DIAGNOSIS; DISTANT METASTASIS; ELECTROSTIMULATION THERAPY; FOLLOW UP; HUMAN; KERATOACANTHOMA; MICROSURGERY; PATHOGENESIS; PHOTODYNAMIC THERAPY; PRECANCER; REVIEW; RISK ASSESSMENT; SKIN BIOPSY; SKIN CARCINOMA; SKIN DEFECT; SUN EXPOSURE; SYSTEMIC THERAPY; TOPICAL TREATMENT; TREND STUDY; CARCINOMA, SQUAMOUS CELL; CLASSIFICATION; PATHOLOGY; PROGNOSIS; SECONDARY; SKIN NEOPLASMS;

CARCINOMA, SQUAMOUS CELL; HUMANS; PROGNOSIS; SKIN NEOPLASMS;

EID: 84921459209     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12553     Document Type: Review

References (80)

1. Miller DL, Weinstock MA. Non-melanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774-778.
2. National Cancer Institute. Squamous Cell Carcinoma. http://www.cancer.gov/cancertopics/pdq/genetics/skin/HealthProfessional/page3. [accessed 18 August 2013].
3. Suurmond D. Section 11. Precancerous lesions and cutaneous carcinomas. In: Suurmond D, ed. Fitzpatrick's Color Atlas & Synopsis of Clinical Dermatology, 6th edn. New York, NY: McGraw-Hill, 2009: http://www.accessmedicine.com/content.aspx?aID=5186831. [Accessed 24 November, 2012].
4. Stern RS. PUVA Follow-Up Study. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol 2012; 66: 553-562.
5. Kreimer-Erlacher H, Seidl H, Back B, et al. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients. Photochem Photobiol 2001; 74: 323-330.
6. McCall CO, Chen SC. Squamous cell carcinoma of the legs in African Americans. J Am Acad Dermatol 2002; 47: 524-529.
7. Sheil AG, Disney APS, Mathew TG, et al. Malignancy following renal transplantation. Transplant Proc 1992; 24: 1946-1947.
8. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 1994; 9: 99-109.
9. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146(Suppl. 61): 1-6.
10. Lichon V, Khachemoune A. Xeroderma pigmentosum: beyond skin cancer. J Drugs Dermatol 2007; 6: 281-288.
11. Cleaver JE. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 2005; 5: 564-573.
12. Papadakis MA, McPhee SJ. Actinic Keratosis. Quick Medical Diagnosis and Treatment, New York: McGraw-Hill, 2014. http://accessmedicine.mhmedical.com.ezproxyhost.library.tmc.edu/content.aspx?bookid=548&Sectionid=45863732. [Accessed 12 March, 2014].
13. Markopoulos A, Albanidou-Farmaki E, Kayavis I. Actinic cheilitis: clinical and pathologic characteristics in 65 cases. Oral Dis 2004; 10: 212-216.
14. American Cancer Society. Cancer facts and figures: 2004. http://www.xxxx. [accessed 2 February 2011].
15. Chalva PL, Mabula JB, Rambau P, et al. Marjolin's ulcers at a university teaching hospital in Northwestern Tanzania: a retrospective review of 56 cases. World J Surg Oncol 2012; 10: 38-45.
16. Esther RJ, Lamps L, Schwartz HS. Marjolin ulcers: secondary carcinomas in chronic wounds. J South Orthop Assoc 1999; 8: 181-187.
17. Turegun M, Nisanci M, Guler M. Burn scar carcinoma with longer lag period arising in previously grafted area. Burns 1997; 23: 496-497.
18. Robinson JW, Brownstein S, Jordan DR, et al. Conjunctival mucoepidermoid carcinoma in a patient with ocular cicatricial pemphigoid and a review of the literature. Surv Ophthalmol 2006; 51: 513-519.
19. Williams LS, Mancuso AA, Mendenhall WM. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int J Radiat Oncol Biol Phys 2001; 49: 1061-1069.
20. Moy RL, Eliezri YD, Nuovo GJ, et al. Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. JAMA 1989; 261: 2669-2673.
21. Ackerman AB. Opposing views of two academies about the nature of solar keratosis. Cutis 2003; 71: 391-395.
22. Goldberg LH, Joseph AK, Tschen JA. Proliferative actinic keratosis. Int J Dermatol 1994; 33: 341-345.
23. Straif K, Benbrahim-Tallaa L, Baan R, et al. A review of human carcinogens - part C: metals, arsenic, dusts, and fibers. Lancet Oncol 2009; 10: 453-454.
24. Ueda A, Suda K, Matsumoto T, et al. A clinicopathological and immunohistochemical comparison of squamous cell carcinoma arising in scars versus non-scar SCC in Japanese patients. Am J Dermatopathol 2006; 28: 472-477.
25. Nancy WB. Keratoacanthoma. RDH 2011; 31: 68-90.
26. Goldberg LH, Silapunt S, Beyrau KK, et al. Keratoacanthoma as a postoperative complication of skin cancer excision. J Am Acad Dermatol 2004; 50: 753-758.
27. Hybarger C. Cutaneous malignant neoplasms. In: Lalwani AK, ed. Current Diagnosis and Treatment in Otolaryngology - Head and Neck Surgery, 3rd edn. New York, NY: McGraw-Hill, 2012: 235-252.
28. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005; 32(Suppl. 1): 7-15.
29. Kamper N, Day PM, Nowak T, et al. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 2006; 80: 759-768.
30. Farzan SF, Waterboer T, Gui J, et al. Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study. Int J Cancer 2013; 133: 1713-1720.
31. Bouwes Bavinck JN, Neale RE, Abeni D, et al. Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 2010; 70: 9777-9786.
32. Forslund O, Iftner T, Andersson K, et al. Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 2007; 196: 876-883.
33. Salem SA, Zuel-Fakkar NM, Fathi G, et al. Comparative study of human papilloma virus in untreated and ultraviolet-treated psoriatic patients. Photodermatol Photoimmunol Photomed 2010; 26: 78-82.
34. Frazer IH, Bhat P, Mattarollo SR, et al. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy. Immunol Rev 2011; 239: 85-98.
35. Hazard K, Karlsson A, Andersson K, et al. Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol 2006; 127: 116-119.
36. Shayanfar N, Hosseini N, Panahi M, et al. Detection of mucosal type human papillomavirus in cutaneous squamous cell carcinoma in Iran. Pathol Res Pract 2013; 209: 90-94.
37. Forslund O, Antonsson A, Nordin P, et al. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumors and normal skin. J Gen Virol 1999; 80: 2437-2443.
38. Forslund O, Ly H, Reid C, et al. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 2003; 149: 64-73.
39. Duncan KO, Geisse JK, Leffell DJ. Epithelial precancerous lesions. In: Goldsmith LA, Katz SI, Gilchrest BA, et al., eds. Fitzpatrick's Dermatology in General Medicine, 8th edn. New York, NY: McGraw-Hill, 2012: 21: 113.
40. Vazquez V, Sergio SS, Capuzzo R. Advanced squamous cell carcinoma of the skin, squamous cell carcinoma. 2012. http://www.intechopen.com/books/squamous-cell-carcinoma/advanced-squamous-cellcarcinoma-of-the-skin. [accessed 22 August, 2013].
41. Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification - part two. J Cutan Pathol 2006; 33: 261-279.
42. Miller SJ. The National Comprehensive Cancer Network (NCCN) guidelines of care for non-melanoma skin cancers. Dermatol Surg 2000; 26: 289-292.
43. O'Brien CJ, McNeil EB, McMahon JD, et al. Significance of clinical stage, extent of surgery, and pathological findings in metastatic cutaneous squamous cell carcinoma of the parotid gland. Head Neck 2002; 24: 417-422.
44. Palme CE, MacKay SG, Kaly I, et al. The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2007; 15: 103-106.
45. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer 2006; 106: 1078-1083.
46. D'Souza J, Clark J. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2011; 19: 99-105.
47. Oddone N, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 2009; 115: 1883-1891.
48. Farasat S, Yu SS, Neel VA, et al. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011; 64: 1051-1059.
49. Peat B, Insull P, Ayers R. Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg 2012; 82: 230-233.
50. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992; 27: 241-248.
51. Mohs FE. Chemosurgical treatment of cancer of the lip. Arch Surg 1944; 48: 478-488.
52. Kropp L, Balamucki CJ, Morris CG, et al. Mohs resection and postoperative radiotherapy for head and neck cancers with incidental perineural invasion. Am J Otolaryngol 2013; 34: 373-377.
53. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis and survival rates in squamous cell carcinoma of the skin, ear and lip. J Am Acad Dermatol 1992; 26: 976-990.
54. Chuang GS, Lu LK, Cummins DL, et al. Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery. Dermatol Surg 2012; 38: 1456-1460.
55. Stern RS. Cost-effectiveness of Mohs micrographic surgery. J Invest Dermatol 2013; 133: 1129-1131.
56. Tromovitch TA. Skin cancer. Treatment by curettage and desiccation. Calif Med 1965; 103: 107-108.
57. Knox JM, Freeman RG, Duncan WC, et al. Treatment of skin cancer. South Med J 1967; 60: 241-246.
58. Freeman RG, Knox JM, Heaton CL. The treatment of skin cancer. A statistical study of 1, 341 skin tumors comparing results obtained with irradiation, surgery and curettage followed by electrodesiccation. Cancer 1964; 17: 535-538.
59. Reschly MJ, Shenefelt PD. Controversies in skin surgery: electrodessication and curettage versus excision for low-risk, small, well-differentiated squamous cell carcinomas. J Drugs Dermatol 2010; 9: 773-776.
60. Chiller K, Passaro D, McCalmont T, et al. Efficacy of curettage before excision in clearing surgical margins of non-melanoma skin cancer. Arch Dermatol 2000; 136: 1327-1332.
61. Kuflik EG, Gage AA. The five-year cure rate achieved by cryosurgery for skin cancer. J Am Acad Dermatol 1991; 24: 1002-1004.
62. Kuflik EG. Cryosurgery for skin cancer: 30-year experience and cure rates. Dermatol Surg 2004; 30: 297-300.
63. Almeida GJ. Advanced cancer of the extremities treated by cryosurgery. G Ital Dermatol Venereol 2011; 146: 249-255. [Erratum in: G Ital Dermatol Venereol 2011; 146: XXII.]
64. Bath-Hextall FJ, Matin RN, Wilkinson D, et al. Interventions for cutaneous Bowen's disease. Cochrane Database Syst Rev 2013; 6: CD007281.
65. Locke J, Karimpour S, Young G. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys 2001; 51: 748-755.
66. Inaba K, Ito Y, Suzuki S, et al. Results of radical radiotherapy for squamous cell carcinoma of the eyelid. J Radiat Res 2013; 54: 1131-1137.
67. Shokrani P, Baradaran-Ghahfarokhi M, Zadeh MK. A novel approach in electron beam radiation therapy of lips carcinoma: a Monte Carlo study. Med Phys 2013; 40: 041720.
68. Najim M, Cross S, Gebski V, et al. Early-stage squamous cell carcinoma of the lip: the Australian experience and the benefits of radiotherapy in improving outcome in high-risk patients after resection. Head Neck 2012; 35: 1426-1430.
69. Hunt WT, Cameron A, Craig P, et al. Multiple-digit periungual Bowen's disease: a novel treatment approach with radiotherapy. Clin Exp Dermatol 2013; 38: 857-861.
70. Stebbins WG, Hanke CW. MAL-PDT for difficult to treat non-melanoma skin cancer. Dermatol Ther 2011; 24: 82-93.
71. Calzavara-Pinton PG, Venturini M, Sala R, et al. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Br J Dermatol 2008 l; 159: 137-144.
72. Fai D, Arpaia N, Romano I, et al. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients. G Ital Dermatol Venereol 2009; 144: 281-285.
73. Calzavara-Pinton PG, Rossi MT. Sala R; Italian Group for Photodynamic Therapy. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 2: oncologic and infectious indications. Photochem Photobiol Sci 2013; 12: 158-165.
74. Lansbury L, Leonardi-Bee J, Perkins W, et al. Interventions for non-metastatic squamous cell carcinoma of the skin. Cochrane Database Syst Rev 2010; 4: CD007869.
75. Hamouda B, Jamila Z, Najet R, et al. Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum. J Am Acad Dermatol 2001; 44: 1054.
76. Welch ML, Grabski WJ, McCollough ML, et al. 5-Fluorouracil iontophoretic therapy for Bowen's disease. J Am Acad Dermatol 1997; 36: 956-958.
77. DeConti RC. Chemotherapy of squamous cell carcinoma of the skin. Semin Oncol 2012; 39: 145-149.
78. Breuninger H, Langer B, Rassner G. Untersuchungen zur Prognosebestimmung des spinozellularen karzinoms der Haut und Unterlippe anhand des TNM-Systems und zusatzlicher Parameter. Hautarzt 1988; 39: 430-434.
79. Jambusaria-Pahlajani A, Miller CJ, Quon H, et al. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg 2009; 35: 574-585.
80. Brantsch KD, Meisner C, Schonfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous cell carcinoma: a prospective study. Lancet Oncol 2008; 9: 713-720.